Publications by authors named "S al-Suwayeh"

Milk contaminated with aflatoxin can lead to liver cancer. Aflatoxin B1 (AFB1), a serious animal feed contaminant, is transformed into Aflatoxin M1 (AFM1) and secreted in milk. In this study, a biological method using probiotic bacteria, () in combination with (), was used to assess their antiaflatoxigenic effect in animal milk.

View Article and Find Full Text PDF
Article Synopsis
  • * A specific formulation, LORNE12-Gel, was developed, showing improved skin permeation, retention, and anti-inflammatory effects compared to regular LOR-Gel.
  • * LORNE12-Gel also demonstrated safety with no skin irritation, suggesting it could be a promising alternative for anti-inflammatory therapies.
View Article and Find Full Text PDF

The present study aims to design and optimize the lornoxicam dispersible tablet (LXDT) formulation using the Quality by design (QbD) approach. A randomized Box-Behnken experimental design was used to characterize the effect of the critical factors, such as filler (MCC/Mannitol) ratio, mixing time, and disintegrant concentration, and assessed for their impacts on the critical quality attributes (responses), including dispersibility time, friability, dissolution efficiency, and content uniformity, respectively. The drug-excipients interaction of the formulation was investigated using FTIR and DSC, respectively.

View Article and Find Full Text PDF

Surfactant-stabilized mucoadhesive nanogels (NGs) for vaginal delivery of fluconazole (FLZ) were studied and evaluated in this work. FLZ-NG formulations were prepared using two different types of mucoadhesive polymers, Carbopol 934 (Ca934) and Pluronic F-127 (PF127). A rheology study revealed a non-Newtonian pseudoplastic flow behavior (shear thinning) in the prepared NGs.

View Article and Find Full Text PDF

The aim of this work was to develop self-nanoemulsifying liquisolid tablets (SNELT) to enhance the dissolution profile of poorly water-soluble simvastatin. SNELT present a unique technique of incorporating self-nanoemulsifying drug delivery systems (SNEDDS) into tablets. Optimized SNEDDS containing different oils, Cremophor RH 40 (surfactant) and Transcutol HP (co-surfactant), at different ratios, were used as liquid vehicles and loaded on carrier material, microcrystalline cellulose (MCC), and coating material, Cab-o-sil H-5 (nanosize colloidal silicon dioxide) powders at different loading factors (L ) and fixed excipient ratio (R = 20).

View Article and Find Full Text PDF